Objectives: To compare the clinical outcomes and mortality rates of Aboriginal and Torres Strait Islander people of Kimberley origin receiving haemodialysis (HD) treatment with other subsets of Aboriginal and Torres Strait Islander HD patients (Northern Territory, Western Australia excluding the Kimberley region, the rest of Australia) and Australian non-Indigenous HD patients.
Design, participants and setting: Retrospective identification of Aboriginal and Torres Strait Islander patients of Kimberley origin and analysis of secondary data from the Australia and New Zealand Dialysis and Transplant Registry; this group was compared with other Australian patients receiving HD treatment from 1 January 2003 to 31 December 2007.
Main outcome measures: Clinical outcome measures; comorbid conditions; death rates per 100 patient-years, unadjusted and adjusted (for age, sex, comorbid conditions, late referral to nephrologist treatment).
Results: Seventy per cent of HD treatments for Aboriginal and Torres Strait Islander patients of Kimberley origin was provided in the Kimberley. They had comparable adjusted mortality rates to non-Indigenous Australian patients (adjusted mortality rate ratio, 0.80; 95% CI, 0.51–1.23).
Conclusions: This is the first report showing similar mortality rates for Aboriginal and Torres Strait Islander people exclusively from a remote area of Australia and non-Indigenous Australians receiving HD treatment. HD treatment delivered closer to home can be safe and effective in remote areas.
- 1. Cass A, Cunningham J, Wang Z, Hoy W. Regional variation in the incidence of end-stage renal disease in Indigenous Australians. Med J Aust 2001; 175: 24-27. <MJA full text>
- 2. Cass A, Gillin AG, Horvath JS. End-stage renal disease in Aboriginals in New South Wales: a very different picture to the Northern Territory. Med J Aust 1999; 171: 407-410. <MJA full text>
- 3. Kneipp E, Murray R, Warr K, et al. Bring me home: renal dialysis in the Kimberley. Nephrology 2004; 9 Suppl 4: S121-S125.
- 4. Rivalland P. Western Desert Nganampa Walytja Palyantjaku Tjutaku: “Making all our families well”. Casuarina, NT: Western Desert Nganampa Walytja Palyantjaku Tjutaku Aboriginal Corporation and Cooperative Research Centre for Aboriginal Health, 2006.
- 5. Spencer JL, Silva DT, Snelling P, et al. An epidemic of renal failure among Australian Aboriginals. Med J Aust 1998; 168: 537-541. <MJA full text>
- 6. Cass A, Cunningham J, Snelling P, et al. Exploring the pathways leading from disadvantage to end-stage renal disease for indigenous Australians. Soc Sci Med 2004; 58: 767-785.
- 7. Devitt J, McMasters A. “They don’t last long”: Aboriginal patient experience of end-stage renal disease in Central Australia. Nephrology 1998; 4: S111-S117.
- 8. Denhaerynck K, Manhaeve D, Dobbels F, et al. Prevalence and consequences of nonadherence to hemodialysis regimens. Am J Crit Care 2007; 16: 222-235; quiz 236.
- 9. Jose M, Livingston B, McDonald S, et al. End-stage kidney disease among indigenous peoples of Australia and NZ. In: McDonald S, Excell L, Livingston B, editors. ANZDATA registry report, 2008. Adelaide: Australia New Zealand Dialysis Transplant Registry; 2008.
- 10. Biddle N. Ranking regions: revisiting an index of relative Indigenous socioeconomic outcomes. Working Paper No. 50/2009. Canberra: Centre for Aboriginal Economic Policy Research, Australian National University, 2009. http://caepr.anu.edu.au/Publications/WP/2009WP50.php (accessed Sep 2010).
- 11. Taylor J. The relative socioeconomic status of Indigenous people in the Kimberley. A report to the Kimberley Land Council. Canberra: Centre for Aboriginal Economic Policy Research, Australian National University, 2009.
- 12. CARI. Caring for Australasians with Renal Impairment. CARI guidelines. http://www.cari.org.au/guidelines.php (accessed Sep 2010).
- 13. Devitt J, Cass A, Cunningham J, et al. Study protocol — Improving Access to Kidney Transplants (IMPAKT): a detailed account of a qualitative study investigating barriers to transplant for Australian Indigenous people with end-stage kidney disease. BMC Health Serv Res 2008; 8: 31.
- 14. Ravani P, Brunori G, Mandolfo S, et al. Cardiovascular comorbidity and late referral impact arteriovenous fistula survival: a prospective multicenter study. J Am Soc Nephrol 2004; 15: 204-209.
- 15. Polkinghorne KR, McDonald SP, Atkins RC, et al. Vascular access and all-cause mortality: a propensity score analysis. J Am Soc Nephrol 2004; 15: 477-486.
- 16. Winkelmayer WC, Owen WF Jr, Levin R, et al. A propensity analysis of late versus early nephrologist referral and mortality on dialysis. J Am Soc Nephrol 2003; 14: 486-492.
- 17. Roderick P, Armitage A, Nicholson T, et al. A clinical and cost evaluation of hemodialysis in renal satellite units in England and Wales. Am J Kidney Dis 2004; 44: 121-131.
- 18. Saran R, Bragg-Gresham JL, Rayner HC, et al. Nonadherence in hemodialysis: associations with mortality, hospitalization, and practice patterns in the DOPPS. Kidney Int 2003; 64: 254-262.
- 19. Stewart MA. Effective physician-patient communication and health outcomes: a review. CMAJ 1995; 152: 1423-1433.
- 20. Rocco MV, Frankenfield DL, Hopson SD, et al. Relationship between clinical performance measures and outcomes among patients receiving long-term hemodialysis. Ann Intern Med 2006; 145: 512-519.
- 21. Nissenson AR, Collins AJ, Dickmeyer J, et al. Evaluation of disease-state management of dialysis patients. Am J Kidney Dis 2001; 37: 938-944.
- 22. Nissenson AR. What common practices in dialysis units can be altered to improve patient care? Semin Dial 2004; 17: 12-13.
Publication of your online response is subject to the Medical Journal of Australia's editorial discretion. You will be notified by email within five working days should your response be accepted.